Criminology - Top Open Access Journals

High Impact List of Articles

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Linaclotide for irritable bowel syndrome with constipation: a review Michael Arriaga & Eamonn MM Quigley

  Drug Evaluation: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Adaptive designs for Phase II oncology trials Meinhard Kieser, Stefan Englert, Geraldine Rauch

  Commentary: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials Jurgen Hummel, Song Wang & John Kirkpatrick

  Clinical Trail Methodology: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• Dual treatment approach may be the key to combating glioblastoma multiforme

  News and Views: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

• The European Network of Gynecological Oncology Trial groups Vergote I, Pujade-Lauraine E, Pignata S, Kristensen GB, Ledermann J, Casado A, Sehouli J, Mirza M, Fossati R, Marth C, Ottevanger N, Del Campo J,Siddiqui N, Calvert P, Bamias A, Tulunay G, Van der Zee AGJ, du Bois A

  Research Update: Clinical Investigation

Relevant Topics in Clinical